Co-Authors
This is a "connection" page, showing publications co-authored by Hermann Laferl and Bernd Jilma.
Connection Strength
0.235
-
Correction to: COVID-19 is not "just another flu": a real-life comparison of severe COVID-19 and influenza in hospitalized patients in Vienna, Austria. Infection. 2021 Oct; 49(5):917.
Score: 0.061
-
High Dose Lopinavir/Ritonavir Does Not Lead to Sufficient Plasma Levels to Inhibit SARS-CoV-2 in Hospitalized Patients With COVID-19. Front Pharmacol. 2021; 12:704767.
Score: 0.060
-
COVID-19 is not "just another flu": a real-life comparison of severe COVID-19 and influenza in hospitalized patients in Vienna, Austria. Infection. 2021 Oct; 49(5):907-916.
Score: 0.059
-
Hydroxychloroquine versus lopinavir/ritonavir in severe COVID-19 patients : Results from a real-life patient cohort. Wien Klin Wochenschr. 2021 Apr; 133(7-8):284-291.
Score: 0.056